Intranasal Insulin for Weight Management During Smoking Cessation
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This FDA-approved (IND# 120700) study will evaluate efficacy of intranasal insulin in
reducing snack intake and reducing postprandial free fatty acid levels in abstinent smokers.